Chitosan-based crosslinking for controlled topical drug release in rhinosinusitis

Int Forum Allergy Rhinol. 2024 Nov;14(11):1802-1805. doi: 10.1002/alr.23413. Epub 2024 Jul 11.

Abstract

Chitosan is a promising drug delivery vector for therapeutics owing to its biocompatibility. Once crosslinked with chitosan, prolonged drug release was noted regardless of hydrophilicity. Hydrophilic drugs may require different strategies to obtain a sustained release profile.

Keywords: chitosan; ciprofloxacin; rhinosinusitis; topical drug release; topical steroid.

MeSH terms

  • Administration, Topical
  • Animals
  • Chitosan* / chemistry
  • Cross-Linking Reagents / chemistry
  • Delayed-Action Preparations*
  • Drug Delivery Systems
  • Drug Liberation
  • Humans
  • Rhinitis* / drug therapy
  • Rhinosinusitis
  • Sinusitis* / drug therapy

Substances

  • Chitosan
  • Delayed-Action Preparations
  • Cross-Linking Reagents